Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Argus Health
Merck
Moodys
Citi
Boehringer Ingelheim
Teva
Queensland Health

Generated: October 16, 2018

DrugPatentWatch Database Preview

Sagent Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?

SAGENT PHARMS has sixty-eight approved drugs.

There is one tentative approval on SAGENT PHARMS drugs.

Summary for Sagent Pharms
US Patents:0
Tradenames:55
Ingredients:52
NDAs:68

Drugs and US Patents for Sagent Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040888-002 Jul 18, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 090834-001 Nov 12, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 078274-002 Dec 29, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040888-003 Jul 18, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKinsey
Cantor Fitzgerald
Fish and Richardson
Federal Trade Commission
QuintilesIMS
Accenture
Chinese Patent Office
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.